
- /
- Supported exchanges
- / US
- / EOLS.NASDAQ
Evolus Inc (EOLS NASDAQ) stock market data APIs
Evolus Inc Financial Data Overview
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Evolus Inc data using free add-ons & libraries
Get Evolus Inc Fundamental Data
Evolus Inc Fundamental data includes:
- Net Revenue: 266 M
- EBITDA: -21 938 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-04
- EPS/Forecast: 0.0223
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evolus Inc News

Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now?
We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now.In this article, we are going to take a look at where Evolus, Inc. (NASDAQ:EOLS) stands against the other small cap pharma...


Evolus, Inc. (EOLS): Is It One of Caligan Partners’ Top Holdings Now?
We recently compiled a list of the Top 10 Holdings of Caligan Partners.In this article, we are going to take a look at where Evolus, Inc. (NASDAQ:EOLS) stands against Caligan Partners' other top holdi...

11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in thi...

10 Stocks George Soros and Insiders Are Crazy About
In this article, we will take a detailed look at the 10 Stocks George Soros and Insiders Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks George Soros and Insiders Are C...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.